- 201. Organization, agency, department
- (UMLS (HL7) C1547903) =Organization =HL7 Vocabulary Version 2.5;
=Department of Defense;
American Express;
Drug Enforcement Agency;
Master Card;
Veterans Affairs;
Visa;
| - 251. OROFACIAL DYSKINESIA
- (UMLS (ICD9CM) C0152115) =Disease or Syndrome ;
|
- 202. organizational contact
- [A contact for an organization for administrative purposes. Contact role specifies a person acting as a liason for the organization. Example: HR Department representative. ( HL7V3.0 )] (UMLS (HL7) C1552575) =Intellectual Product =AdministrativeContactRoleType;
| - 252. OromucosalRoute
- [Oromucosal ( HL7V3.0 )] (UMLS (HL7) C1699296) =Functional Concept ;
=RouteBySite;
=Gargle;
Suck, oromucosal;
Swish and spit out, oromucosal;
Swish and swallow, oromucosal;
Topical application, oromucosal |
- 203. Organizational name type
- (UMLS (HL7) C1547614) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Alias name;
Display Name;
Legal Name;
Stock exchange listing name;
| - 253. Oropharyngeal Cancer Stage IV
- [The tumor has spread to the hard palate, tongue, or larynx, to nearby lymph nodes, and may have spread to other parts of the body. ( NCI )] (UMLS (NCI) C1378462) Stage IV Carcinoma of Oropharynx;
Stage IV Carcinoma of the Oropharynx;
Stage IV Oropharyngeal Cancer;
Stage IV Oropharyngeal Carcinoma;
stage IV oropharynx cancer;
Stage IV Oropharynx Carcinoma;
=Neoplastic Process |
- 204. OrganizationEntityType
- [Further classifies entities of classCode ORG. ( HL7V3.0 )] (UMLS (HL7) C1698961) =Intellectual Product =EntityCode;
=religious institution;
| - 254. Oropharyngeal Cancer, Recurrent
- [The reemergence of oropharyngeal cancer after a period of remission. ( NCI )] (UMLS (NCI) C0279838) =Neoplastic Process
|
- 205. OrganizationNamePartQualifier
- (UMLS (HL7) C1698247) =Idea or Concept =EntityNamePartQualifier;
=Legal status;
| - 255. Oropharyngeal Cancer, Stage I
- [Cancer that is no larger than 2 centimeters (about 0.75 inch) and is confined to the oropharynx. ( NCI )] (UMLS (NCI) C0279834) =Neoplastic Process
|
- 206. OrganizationNameType
- (UMLS (HL7) C1553733) =Intellectual Product =CodeSystem;
=Legal;
Alias;
Stock exchange | - 256. Oropharyngeal Cancer, Stage II
- [Tumor that is between 2 and 4 centimeters (0.75 and 1.5 inches) and is confined to the oropharynx. ( NCI )] (UMLS (NCI) C0279835) =Neoplastic Process
|
- 207. OrganizationNameUse
- (UMLS (HL7) C1698256) =Idea or Concept =EntityNameUse;
=Legal;
License;
NameRepresentationUse;
| - 257. Oropharyngeal Cancer, Stage III
- [The tumor is larger than 4 centimeters (about 1.5 inches) in size and may involve a single lymph node on the same side of the neck. ( NCI )] (UMLS (NCI) C0279836) =Neoplastic Process
|
- 208. OrganizationPartRoleType
- (UMLS (HL7) C1700316) =Intellectual Product ;
=RoleCode;
| - 258. Oropharyngeal Candidiasis
- [Infection of the oropharynx with, or disease caused by, Candida, especially C. albicans. This disease usually results from debilitation (as in immunosuppression and especially AIDS), physiologic change, prolonged administration of antibiotics, and iatrogenic and barrier breakage. SYN candidosis, moniliasis. ( NCI )] (UMLS (NCI) C0919659) oropharyngeal thrush =Disease or Syndrome ;
|
- 209. organized financing
- [all organized methods of funding by federal, state, and local agencies, as well as private organizations. ( CSP )] (UMLS (CSP) C0016121) =Idea or Concept =socioeconomics;
=income maintenance | - 259. Oropharyngeal Papilloma
- (UMLS (NCI) C1335141) Oropharyngeal Squamous Papilloma;
Oropharynx Papilloma;
Papilloma of Oropharynx;
Papilloma of the Oropharynx;
Squamous Papilloma of Oropharynx;
Squamous Papilloma of the Oropharynx =Neoplastic Process ;
|
- 210. Organized Village of Grayling (aka Holikachuk)
- (UMLS (HL7) C1550865) =Population Group =NativeEntityAlaska;
| - 260. Oropharyngeal Polyp
- (UMLS (NCI) C1335140) Oropharynx Polyp;
Polyp of Oropharynx;
Polyp of the Oropharynx;
=Neoplastic Process ;
|
- 211. Organized Village of Kake
- (UMLS (HL7) C1550881) =Population Group =NativeEntityAlaska;
| - 261. OropharyngealRoute
- [Oropharyngeal ( HL7V3.0 )] (UMLS (HL7) C1701808) =Functional Concept =RouteBySite;
=Topical application, oropharyngeal |
- 212. Organized Village of Kasaan
- (UMLS (HL7) C1550887) =Population Group =NativeEntityAlaska;
| - 262. Oropharynx Epithelium
- (UMLS (NCI) C1179158) =Tissue ;
|
- 213. Organized Village of Kwethluk
- (UMLS (HL7) C1550906) =Population Group =NativeEntityAlaska;
| - 263. Oropouche virus
- [ ] (UMLS (CSP) C0318946) =Virus
|
- 214. Organized Village of Saxman
- (UMLS (HL7) C1550978) =Population Group =NativeEntityAlaska;
| - 264. orotate
- [the 4-carboxylate derivative of uracil, a metabolic intermediate. ( CSP )] (UMLS (CSP) C0178785) =Organic Chemical; Biologically Active Substance ;
=Pyrimidine;
|
- 215. organizer
- [Organizer of entries. Navigational. No semantic content. Knowledge of the section code is not required to interpret contained observations. Represents a heading in a heading structure, or "organizer tree". The record entries relating to a single clinical session are usually grouped under headings that represent phases of the encounter, or assist with layout and navigation. Clinical headings usually reflect the clinical workflow during a care session, and might also reflect the main author's reasoning processes. Much research has demonstrated that headings are used differently by different professional groups and specialties, and that headings are not used consistently enough to support safe automatic processing of the E H R. ( HL7V3.0 )] (UMLS (HL7) C1555711) =Idea or Concept =ActClassContainer;
=document section;
document body;
topic;
category | - 265. orotate phosphoribosyltransferase
- [The enzyme catalyzing the formation of orotidine-5'-phosphoric acid (orotidylic acid) from orotic acid and 5-phosphoribosyl-1-pyrophosphate in the course of pyrimidine nucleotide biosynthesis. EC 2.4.2.10. ( MSH )] (UMLS (CSP) C0029298) =Amino Acid, Peptide, or Protein; Enzyme ;
=pentosyltransferase;
|
- 216. organogenesis
- [Formation of organs during development. ( NCI )] (UMLS (CSP) C0242290) =Biologic Function
| - 266. orotate phosphoribosyltransferase deficiency
- [excess of orotic acid in the urine occurring in several metabolic disorders and also resulting from the administration of some drugs; one disorder is an autosomal recessive defect of pyrimidine metabolism due to deficiency of orate phosphoribosyltransferate or orotidine 5'-phosphatae decarboxylase. ( CSP )] (UMLS (CSP) C0268128) =Disease or Syndrome ;
=Anemia, Megaloblastic;
Arrieration mentale;
purine/pyrimidine metabolism disorder;
enzyme deficiency |
- 217. Organoid Pattern
- (UMLS (NCI) C1335133) =Finding ;
| - 267. orotidine 5 phosphate decarboxylase
- [Orotidine-5'-phosphate carboxy-lyase. Catalyzes the decarboxylation of orotidylic acid to yield uridylic acid in the final step of the pyrimidine nucleotide biosynthesis pathway. EC 4.1.1.23. ( MSH )] (UMLS (CSP) C0029303) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 218. Organometallic Compound
- [organic compound containing a metal linked to carbon. ( CSP )] (UMLS (NCI) C0029252) =Organic Chemical =Organic Chemical;
metal complex =metalloporphyrin;
iron compound;
Antimony Potassium Tartrate;
Arsenic Compound;
Ferric Compounds;
Ferrous Compounds;
aurothioglucose;
Gold Sodium Thiomalate;
Organomercury Compounds;
Organoplatinum Compounds;
Organotechnetium Compounds;
sucralfate;
bismuth subgallate;
Bismuth Subsalicylate;
GADOTERIDOL;
Gadolinium DTPA;
CALCIUM GLUBIONATE;
IRON CARBONYL;
lead acetate;
2-Mercaptopyridine 1-oxide Zinc Salt;
Citrate of Magnesia;
Ca-DTPA;
Optimark | - 268. ORP _ Pharmacy/treatment order acknowledgment
- (UMLS (HL7) C1549246) =Health Care Activity =Event Type;
|
- 219. Organon Teknika Corporation
- [Organon Teknika Corporation ( HL7V3.0 )] (UMLS (HL7) C1546887) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
VaccineManufacturer | - 269. ORP33
- [ ] (UMLS (CSP) C0599793) =Amino Acid, Peptide, or Protein; Enzyme
|
- 220. organophosphorus insecticide
- [class of chemicals composed of an organic radical bound to a phosphorus containing radical that kill insects. ( CSP )] (UMLS (CSP) C0301172) =Organophosphorus Compound; Hazardous or Poisonous Substance =insecticide;
phosphorus compound =phosphamide;
parathion;
| - 270. orphan disease
- [Rare diseases that have not been well studied. ( MSH )] (UMLS (CSP) C0920627) =Disease or Syndrome ;
|
- 221. Organoselenium Compound
- [Organic compounds which contain selenium as an integral part of the molecule. ( MSH )] (UMLS (NCI) C0085153) =Organic Chemical ;
=Organic Chemical;
=Butanoic acid, 2-amino-4-(methylseleno)- | - 271. orphan disease/drug
- [rare diseases and the drugs and other products related to them, so called because development is not profitable; note that this term has nothing to do with orphan children. ( CSP )] (UMLS (CSP) C0178786) =Intellectual Product =Disease;
drug design/synthesis/production |
- 222. organosilicon compound
- [organic compounds that contain silicon as an integral part of the molecule. ( CSP )] (UMLS (CSP) C0206126) =Organic Chemical ;
=Organic Chemical;
silicon compound =silicone rubber;
siloxane | - 272. orphan drug
- [A compound or product that demonstrates promise for the diagnosis and/or treatment of rare diseases and conditions that affect fewer than 200,000 people. The U.S. Orphan Drug Act (1983) encourages development of these therapeutics by tax breaks and a seven-year monopoly on drug sales. These incentives promote the development and manufacturing of such therapeutics, which otherwise might not be profitable because of the small potential market. ( NCI )] (UMLS (CSP) C0013232) =Pharmacologic Substance
|
- 223. ORI _ Imaging order response message to any OMI
- (UMLS (HL7) C1549260) =Health Care Activity =Event Type;
| - 273. Orphan Nuclear Receptor Gene
- [Orphan Nuclear Receptor Genes (NR Superfamily) encode numerous Orphan Nuclear Receptor (NRs) transcription factors thought to be activated by as yet unknown ligands. Transducing cellular signals into gene transcription, NRs regulate development, pattern formation, cell proliferation, cell differentiation, and homeostasis in target tissues. NRs share a common organization: an (N) modulatory domain, a conserved central Cys-rich region of two C4 zinc fingers that bind to specific upstream ligand-responsive target DNA elements, and a (C) ligand-binding domain. Stabilizing hydrophobic zinc finger interactions contribute to DNA binding specificity, homodimerization, and interaction with other proteins. Ligand-bound NR conformation allows coactivator interaction with the ligand-binding domain that mediates interaction with heat shock proteins, cyclophilins, and ligand. (NCI) ( NCI )] (UMLS (NCI) C1335143) =Gene or Genome ;
|
- 224. orientation
- [change of position in response to an external stimulus; for psychological orientation, see PSYCHOLOGICAL ADAPTATION. ( CSP )] (UMLS (CSP) C1704322) Oriented;
=Spatial Concept ;
=environmental adaptation;
=chemotaxis;
| - 274. orphanage
- [Institutions for the housing and care of orphans, foundlings, and abandoned children. They have existed as such since the medieval period but the heading is applicable to such usage also in modern parlance. ( MSH )] (UMLS (CSP) C0337651) =Manufactured Object; Organization
|
- 225. Orifice of Auditory Tube
- (UMLS (NCI) C0926800) Orifice of Eustachian Tube;
Orifice of the Auditory Tube;
Orifice of the Eustachian Tube =Body Space or Junction | - 275. ORPHENADRINE
- [A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. ( MSH )] (UMLS (NCI) C0029309) =Organic Chemical; Pharmacologic Substance ;
=Benzhydryl Compounds;
Ethylamines;
[MS200] SKELETAL MUSCLE RELAXANTS;
=Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenyl)methoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1);
ORPHENADRINE HYDROCHLORIDE;
Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenyl)methoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1);
ORPHENADRINE HYDROCHLORIDE |
- 226. origin
- [The location of origin for services. May be a static building (or room therein) or a movable facility (e.g., ship). ( HL7V3.0 )] (UMLS (HL7) C1550512) =Intellectual Product =location;
| - 276. ORR - Order response (also RRE, RRD, RRG, RRA)
- (UMLS (HL7) C1549238) =Health Care Activity =Event Type;
|
- 227. Original
- [Preceding all others in time or being as first made or performed. ( NCI )] (UMLS (NCI) C0205313) =Idea or Concept
| - 277. ORS _ Stock requisition acknowledgment
- (UMLS (HL7) C1549242) =Health Care Activity =Event Type;
|
- 228. Original mode: Application Accept - Enhanced mode: Application acknowledgment: Accept
- (UMLS (HL7) C1546404) =Intellectual Product =Acknowledgment code;
| - 278. Ortho Diagnostic Systems, Inc.
- [Ortho Diagnostic Systems, Inc. ( HL7V3.0 )] (UMLS (HL7) C1552898) =Health Care Related Organization ;
=VaccineManufacturer;
|
- 229. Original mode: Application Error - Enhanced mode: Application acknowledgment: Error
- (UMLS (HL7) C1546405) =Intellectual Product =Acknowledgment code;
| - 279. Ortho-Clinical Diagnostics.
- (UMLS (HL7) C1546886) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
|
- 230. Original mode: Application Reject - Enhanced mode: Application acknowledgment: Reject
- (UMLS (HL7) C1546406) =Intellectual Product =Acknowledgment code;
| - 280. Orthoclone OKT3
- (UMLS (NCI) C0733466) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
|
- 231. Original, first run
- (UMLS (HL7) C1550161) =Idea or Concept =Analyte repeat status;
| - 281. Orthodon Procedure
- [A dental treatment to correct malocclusions of the teeth and their surrounding structures. ( NCI )] (UMLS (NCI) C0204193) =Therapeutic or Preventive Procedure
|
- 232. originality
- [ ] (UMLS (CSP) C0598240) =Mental Process ;
| - 282. orthodontic appliance
- [appliance which is used for the correction, guidance or adjustment of malformed, injured or diseased dentofacial structure; including those which reposition dental bones. ( CSP )] (UMLS (CSP) C0029331) =Medical Device =dental prosthesis;
=cleft palate prosthesis;
|
- 233. Orimetene
- (UMLS (NCI) C1510870) =Organic Chemical; Pharmacologic Substance
| - 283. orthodontic prosthesis
- [ ] (UMLS (CSP) C0302605) =Medical Device
|
- 234. ORL - General laboratory order response message to any OML
- (UMLS (HL7) C1549258) =Health Care Activity =Event Type;
| - 284. orthodontic service
- [The service provided is required for orthodontic purposes. If the covered party has orthodontic coverage, then the service may be paid. ( HL7V3.0 )] (UMLS (HL7) C1552572) =Intellectual Product =ActInvoiceOverrideCode;
|
- 235. ORL - Laboratory order response message to a single container of a specimen OML
- (UMLS (HL7) C1549272) =Health Care Activity =Event Type;
| - 285. orthodontics
- [dental specialty concerned with the prevention and correction of dental and oral anomalies, irregularities and malocclusions. ( CSP )] (UMLS (CSP) C0029335) =Biomedical Occupation or Discipline =dentistry;
|
- 236. ORL _ Laboratory order response message to a multiple order related to single specimen OML
- (UMLS (HL7) C1549270) =Health Care Activity =Event Type;
| - 286. ORTHODONTICS AFTERCARE
- (UMLS (ICD9CM) C0029336) =Finding
|
- 237. Orlaam
- (UMLS (NCI) C0722317) =Organic Chemical; Pharmacologic Substance ;
| - 287. Orthodontics and Dentofacial Orthopedics
- [That area of dentistry concerned with the supervision, guidance and correction of the growing or mature dentofacial structures, including those conditions that require movement of teeth or correction of malrelationships and malformations of their related structures and the adjustment of relationships between and among teeth and facial bones by the application of forces and/or the stimulation and redirection of functional forces within the craniofacial complex. Major responsibilities of orthodontic practice include the diagnosis, prevention, interception and treatment of all forms of malocclusion of the teeth and associated alterations in their surrounding structures; the design, application and control of functional and corrective appliances; and the guidance of the dentition and its supporting structures to attain and maintain optimum occlusal relations in physiologic and esthetic harmony among facial and cranial structures.1-30-2003 ( HL7V3.0 )] (UMLS (HL7) C1555933) =Intellectual Product =Dentist;
|
- 238. ORLISTAT
- [A reversible active-site inhibitor of gastrointestinal lipases. Orlistat forms a covalent bond with the active serine site in gastric and pancreatic lipases, thereby inhibiting their activity and preventing dietary fat from being hydrolyzed and absorbed. (NCI04) ( NCI )] (UMLS (NCI) C0076275) =Organic Chemical; Pharmacologic Substance ;
=LACTONE;
[GA900] GASTRIC MEDICATIONS, OTHER =ORLISTAT 120 MG | - 288. Orthodontist
- [A dentist specializing in the prevention, diagnosis, and treatment of malocclusions of the teeth and their surrounding structures. ( NCI )] (UMLS (NCI) C0260083) =Professional or Occupational Group ;
|
- 239. ORM - Order message (also RDE, RDS, RGV, RAS)
- (UMLS (HL7) C1549237) =Health Care Activity =Event Type;
| - 289. Orthodox
- (UMLS (HL7) C1552057) =Idea or Concept =Religious Affiliation;
|
- 240. Ormaplatin
- [A platinum(IV) analogue with antineoplastic activity. Also known as tetraplatin, ormaplatin alkylates DNA, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. (NCI04) ( NCI )] (UMLS (NCI) C0076329) =Organic Chemical; Pharmacologic Substance ;
| - 290. Ortholog
- [A gene from one species which corresponds to a gene in another species that is related via a common ancestral species (a homologous gene), but which has evolved to become different from the gene of the other species. ( NCI )] (UMLS (NCI) C1335144) Orthologous Gene;
=Gene or Genome ;
|
- 241. ORN _ Non-stock requisition acknowledgment
- (UMLS (HL7) C1549244) =Health Care Activity =Event Type;
| - 291. Orthomolecular Therapy
- [The use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently for the treatment of mental disorders. ( MSH )] (UMLS (NCI) C0029340) =Therapeutic or Preventive Procedure
|
- 242. Ornidyl
- (UMLS (NCI) C0029275) =Organic Chemical; Pharmacologic Substance ;
| - 292. Orthomyxoviridae disease
- [virus diseases caused by Orthomyxoviridae. ( CSP )] (UMLS (CSP) C0029342) =Disease or Syndrome =respiratory infection;
RNA Virus Infections;
Infection, Viral;
=influenza;
avian flu;
influenza;
|
- 243. ornithine
- [amino acid produced in the urea cycle by the splitting off of urea from arginine; it is not incorporated into proteins. ( CSP )] (UMLS (CSP) C0029277) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Amino Acids, Diamino;
=Alpha-Difluoromethylornithine;
LEVO-ORNITHINE;
| - 293. Orthopaedic Nursing
- [Nursing care with a special emphasis on the care of individuals with orthopaedic-related injuries, diseases, and diagnoses. ( NCI )] (UMLS (NCI) C0085126) =Biomedical Occupation or Discipline ;
|
- 244. ornithine carbamoyltransferase deficiency
- [An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as a sex-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50) ( MSH )] (UMLS (CSP) C0268542) =Disease or Syndrome =Amino Acid Metabolism, Inborn Errors;
| - 294. Orthopaedic Surgery
- (UMLS (HL7) C1555794) =Professional or Occupational Group =Allopathic & Osteopathic Physicians;
=Adult Reconstructive Orthopaedic Surgery;
Foot and Ankle Orthopaedics;
Hand Suvrgery;
Orthopaedic Surgery of the Spine;
Orthopaedic Trauma;
Sports Medicine;
|
- 245. ornithine oxoacid aminotransferase
- [A pyridoxal phosphate enzyme that catalyzes the formation of glutamate gamma-semialdehyde and an L-amino acid from L-ornithine and a 2-keto-acid. EC 2.6.1.13. ( MSH )] (UMLS (CSP) C0029278) =Amino Acid, Peptide, or Protein; Enzyme ;
=aminotransferase;
| - 295. Orthopaedic Surgery of the Spine
- (UMLS (HL7) C1555798) =Intellectual Product =Orthopaedic Surgery;
|
- 246. Ornithodoros
- [A genus of softbacked TICKS, in the family ARGASIDAE, serving as the vector of BORRELIA, causing RELAPSING FEVER, and of the AFRICAN SWINE FEVER VIRUS. ( MSH )] (UMLS (CSP) C0323546) =Invertebrate
| - 296. Orthopaedic Trauma
- (UMLS (HL7) C1555799) =Intellectual Product =Orthopaedic Surgery;
|
- 247. Ornithosis
- [Infection with CHLAMYDOPHILA PSITTACI (formerly Chlamydia psittaci), transmitted to humans by inhalation of dust-borne contaminated nasal secretions or excreta of infected BIRDS. This infection results in a febrile illness characterized by PNEUMONITIS and systemic manifestations. ( MSH )] (UMLS (ICD9CM) C0029291) =Disease or Syndrome =Chlamydophila Infections;
| - 297. Orthopedic
- (UMLS (HL7) C1552304) =Professional or Occupational Group =Physical Therapist;
|
- 248. ORNITHOSIS COMPLICAT NEC
- [ ] (UMLS (ICD9CM) C0153100) =Disease or Syndrome
| - 298. Orthopedic
- (UMLS (HL7) C1555922) =Professional or Occupational Group =Chiropractor;
◊ (UMLS (HL7) C1555999) Professional or Occupational Group Registered Nurse; |
- 249. ORNITHOSIS COMPLICAT NOS
- [ ] (UMLS (ICD9CM) C0153101) =Disease or Syndrome
| - 299. Orthopedic
- [branch of surgery that is especially concerned with the preservation and restoration of the functions of the skeletal system, its articulations and associated structures. ( CSP )] (UMLS (NCI) C0029355) =Biomedical Occupation or Discipline =Operation;
=amputation;
ankylosis (surgical);
arthroplasty;
fracture fixation;
muscle transplantation;
artificial limb;
hip surgery;
intervertebral disk surgery;
musculoskeletal transplantation;
|
- 250. ORNITHOSIS PNEUMONIA
- [ ] (UMLS (ICD9CM) C0153099) =Disease or Syndrome
| - 300. ORTHOPEDIC AFTERCARE NEC
- [ ] (UMLS (ICD9CM) C0260756) =Finding
|
home
